IVOG vs TMSL: Differences, Returns & Fees
IVOG and TMSL hold 27% of their weight in the same names, and TMSL returned +16.9% over the year. Net assets: $1.7bn on Sep 30, 2026 for Vanguard S&P Mid-Cap 400 Growth ETF, and $3.1bn on Oct 20, 2026 for T. Rowe Price Small-Mid Cap ETF.
IVOG costs 0.45 points a year less; their one-year returns differ by 1.9 points.
| IVOG | TMSL | |
|---|---|---|
| Expense ratio | 0.10% | 0.55% |
| Net assets, IVOG as of Sep 30, 2026 and TMSL as of Oct 20, 2026 | $1.7bn | $3.1bn |
| Total return, 1 year | +15.0% | +16.9% |
| What it tracks | S&P MidCap 400 Growth Index | No index, actively managed |
| Holdings in common | 27% | |
| Top ten holdings, share of the fund | 14.7% | 9.8% |
| Below its high | 8.1%, high on Aug 14, 2026 | 8.3%, high on Aug 14, 2026 |
Holdings in common uses holdings dated Jun 30, 2026 and Sep 30, 2026.
IVOG and TMSL are built for the same job. How do they differ in cost, holdings and results?
- What each follows. IVOG follows S&P MidCap 400 Growth Index and TMSL follows No index, actively managed.
- Holdings in common. 27% of the weight is in the same securities (holdings dated Sep 30, 2026 and Jun 30, 2026).
- Cost. IVOG charges 0.10% of assets a year and TMSL 0.55%, a gap of 0.45 points.
Data as of Oct 20, 2026. The differences are picked by a fixed rule, in a fixed order; the PDF prints it. Page 2 has the returns, overlap, risks and sources.
Take this comparison to a client
The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.
Not advice. The brief uses the figures on this page, with the data date and a report id. Saved comparisons are listed on your saved page; privacy.
What they hold in common
By the books each fund has filed, IVOG and TMSL hold 27% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026 and Sep 30, 2026.
half
27% in common
On the same fields
IVOG and TMSL on the fields both publish, as of Oct 20, 2026. Source: ETFIQ.
About IVOG
IVOG tracks an index. Over the year to Oct 20, 2026 it returned +15.0% with distributions reinvested, against +14.9% for its benchmark, the S&P MidCap 400 Growth Index. The prospectus expense ratio is 0.10% a year. By its holdings published by its issuer as of Sep 30, 2026, 3% of the fund by weight is stocks the S&P 500 also holds, across 249 positions, with the top ten at 14.7%. It sat 8.1% below its high of Aug 14, 2026 on Oct 20, 2026.
About TMSL
TMSL is actively managed and tracks no index. The prospectus expense ratio is 0.55% a year. By its holdings filed for Jun 30, 2026, 15% of the fund by weight is stocks the S&P 500 also holds, across 297 positions, with the top ten at 9.8%. It sat 8.3% below its high of Aug 14, 2026 on Oct 20, 2026.
Over the year to Oct 20, 2026 it returned +16.9% with distributions reinvested, against +15.0% for its benchmark, the Russell 3000 Index.
Questions people ask
- Which returned more over the last year, IVOG or TMSL?
- In the year to Oct 20, 2026, with distributions reinvested, IVOG returned +15.0% and TMSL +16.9%.
- Which is cheaper, IVOG or TMSL?
- IVOG is cheaper, by 0.45 percentage points a year. That is about $45 on $10,000 held for a year. Fees come from each fund's prospectus.
ETFIQ links to the documents behind every figure; a link is not an endorsement. A comparison is not a recommendation.
How this is computed
Overlap adds up the smaller of the two weights for each security both funds hold.
Cite this pageCitation, APA and Markdown
ETFIQ, IVOG against TMSL, data as of Oct 20, 2026. https://etfiq.com/compare/any/ivog-vs-tmsl
ETFIQ. (Oct 20, 2026). IVOG against TMSL. Retrieved from https://etfiq.com/compare/any/ivog-vs-tmsl
[IVOG against TMSL (ETFIQ, Oct 20, 2026)](https://etfiq.com/compare/any/ivog-vs-tmsl)
Free to use with attribution for figures ETFIQ computes; issuer data stays under its owner's terms.